pharmaphorum29d
Antares to develop injector pen drug with Pfizer
New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for an undisclosed Pfizer drug, adding 13% to its shares value on Nasdaq.
On-Body Drug Delivery Devices Market Hits US$ 390.7 Million in 2023, Set to Reach US$ 796.1 Million by 2034 with a 6.8% CAGR | TMR Research
The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...
Benzinga.com28d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
A Prescription Drug User Fee Act (PDUFA ... can be administered subcutaneously at home using an autoinjector. The injection process is expected to take, on average, 15 seconds.
Stockton university team develops single-dose injection to counter fentanyl overdose
A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid ...
Healio27d
FDA accepts BLA for Leqembi subcutaneous autoinjector maintenance dosing
The FDA has set a Prescription Drug User Fee Act action date for August 31. Editor's Note: This story was updated on Feb. 4 to clarify the FDA has accepted the biologics license application for a ...
Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2024 ...
Immunovant’s Promising Pipeline: Strategic Advances in FcRn Inhibitors and Market Expansion
Analyst Sam Slutsky of LifeSci Capital maintained a Buy rating on Immunovant (IMVT – Research Report), retaining the price target of ...